CVS Health has teamed up with Fluency, an AI platform backed by Accel, to expand the use of autonomous AI agents across its operations. This partnership aims to overcome the common challenge enterprises face in scaling AI from pilot projects to full production by using real operational data to identify automation opportunities and measure ROI. Fluency’s approach helps CVS integrate AI smoothly into complex workflows like pharmacy operations and insurance coordination, improving efficiency and proving business impact. This move highlights a growing trend among large companies to strategically deploy AI for measurable operational gains.
At the AHIP 2026 conference, CVS Health highlighted its use of AI to reduce administrative burdens and enhance patient care. Their conversational AI assistant helps members navigate insurance and healthcare processes by anticipating needs and providi...
Since 2017, healthcare and social services added about 901,000 jobs while all other sectors lost jobs, highlighting a stark labor market divide. This trend is partly due to slow population growth limiting overall job creation. Despite strong healthca...
Three traditional Dow components—CVS Health, Goldman Sachs, and Caterpillar—have significantly outperformed broader market benchmarks over the past year, driven by their strong market positions, hard-asset moats, and AI integration. CVS Health rose 5...
